Next-generation Sequencing-based genomic profiling: Fostering innovation in cancer care? (2017)
- Authors:
- Autor USP: HOFF, PAULO MARCELO GEHM - FM
- Unidade: FM
- DOI: 10.6061/clinics/2017(10)01
- Subjects: NEOPLASIAS; GENÔMICA; ANÁLISE DE SEQUÊNCIA DE DNA
- Language: Inglês
- Imprenta:
- Source:
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
FERNANDES, Gustavo S. et al. Next-generation Sequencing-based genomic profiling: Fostering innovation in cancer care?. Clinics, v. 72, n. 10, p. 588-594, 2017Tradução . . Disponível em: https://doi.org/10.6061/clinics/2017(10)01. Acesso em: 04 mar. 2026. -
APA
Fernandes, G. S., Marques, D. F., Girardi, D. M., Braghiroli, M. I. F., Coudry, R. A., Meireles, S. I., et al. (2017). Next-generation Sequencing-based genomic profiling: Fostering innovation in cancer care? Clinics, 72( 10), 588-594. doi:10.6061/clinics/2017(10)01 -
NLM
Fernandes GS, Marques DF, Girardi DM, Braghiroli MIF, Coudry RA, Meireles SI, Katz A, Hoff PM. Next-generation Sequencing-based genomic profiling: Fostering innovation in cancer care? [Internet]. Clinics. 2017 ; 72( 10): 588-594.[citado 2026 mar. 04 ] Available from: https://doi.org/10.6061/clinics/2017(10)01 -
Vancouver
Fernandes GS, Marques DF, Girardi DM, Braghiroli MIF, Coudry RA, Meireles SI, Katz A, Hoff PM. Next-generation Sequencing-based genomic profiling: Fostering innovation in cancer care? [Internet]. Clinics. 2017 ; 72( 10): 588-594.[citado 2026 mar. 04 ] Available from: https://doi.org/10.6061/clinics/2017(10)01 - Should patients with advanced colorectal cancer and ECOG 3/4 be treated with chemotherapy?
- Primary prevention of colorectal cancer: Myth or reality?
- Drogas moleculares
- Perspectivas no cuidado dos tumores gastrointestinais
- Obesidade e câncer
- Combination of capecitabine and oxaliplatin is an effective treatment option for advanced neuroendocrine tumors
- Expression of ERCC1, Bcl-2, Lin28a, and Ki-67 as biomarkers of response to first-line platinum-based chemotherapy in patients with high-grade extrapulmonary neuroendocrine carcinomas or small cell lung cancer
- Evidence-based recommendations for gastrointestinal cancers during the COVID-19 pandemic by the Brazilian Gastrointestinal Tumours Group
- Lack of association between ERCC1 expression in biliary tract malignancy and response to chemotherapy
- Combination of irinotecan and a platinum agent for poorly differentiated neuroendocrine carcinomas
Informações sobre o DOI: 10.6061/clinics/2017(10)01 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
